Search

EHA Statement of Solidarity with Ukraine

The European Hematology Association (EHA) is deeply concerned about the situation in Ukraine, the plight of the civilian population, and the damage to healthcare infrastructures.

Read more

Abstract & Clinical Case Submission

Abstract submission is an important part of the 7th European CAR T-cell Meeting.

Read more

Sponsor opportunities

The European Hematology Association (EHA) invites you to support the EHA-SWG Scientific Meeting on Recent Advances in the Pathogenesis and Treatment of Secondary Acute Myeloid Leukemias.

Read more

1st European EHA Sickle Cell Conference

EHA is teaming up with the Annual Scientific Conference on Sickle Cell and Thalassaemia, 2020 and the British Society of Haematology (BSH) to co-organize this first European Sickle Cell Conference; and also as a result of COVID-19 offer it as…

Read more

First Hybrid HOPE meeting in Bangkok, Thailand - a report

Highlights of Past EHA (HOPE) Asia 2022

September 2-3, 2022 – Bangkok, Thailand

Meeting chairs

A Almeida, President, European Hematology Association (EHA)
G Gaidano, Chair Global Outreach Committee, European Hematology Association (EHA)
P Rojnuckarin, President, Thai Society of Hematology (TSH)
S Hongeng, Vice President, Thai Society…

Read more

EHA-SWG Scientific Meeting on Patient-centered Geriatric Hematology - report

Live sessions: October 6-7, 2021

Chairs: Prof R Cordoba (Spain) and Dr V Goede (Germany)

An international group of hematologists, specialist nurses, patient advocates, geriatricians, basic research, and pharma representatives gathered digitally to participate in this meeting.

Read more

Publication of EHA Annual General Meeting 2023 minutes

EHA impact video



 

The 2023 EHA Annual General Meeting (AGM) took place in Frankfurt, Germany on June 9, 2023.

Read more

Sponsor opportunities

EHA and the Lebanese Society of Hematology and Blood Transfusion (LSHBT) have initiated a webinar course dedicated to practitioners who manage patients with benign and hematologic malignancies with the practical tools to translate emerging data into the best therapy for…

Read more